They found that loss of either MAP3K7, a kinase involved in inflammatory signaling, or CHD1, a chromatin-remodeling factor, rendered previously resistant prostate cancer cells highly susceptible to VSV infection and oncolysis. This evidence concerns the gene MAP3K7 and prostate cancer.